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“He who knows syphilis, knows medicine” 
Sir William Osler 
1. Introduction  
1.1 Historical perspectives 
The origins of syphilis have been discussed for many centuries. Two main theories have been 
proposed: The new World or Columbian theory and the world or pre-Columbian theory. The 
Pre-Columbian theory purports that syphilis originated in central Africa and was introduced 
to Europe prior to the voyage by Columbus (Hudson, 1956). The former holds that syphilis 
was endemic in the part of the world now know as Haiti and was then acquired and carried to 
Europe by Columbus in the 1400s (Rothschild,2005). Bacteriological studies efforts the theory 
than the syphilis was introduced by Columbus to the Europe (Harper, 2008). In 1495 there was 
the first syphilis´s epidemic in Europe (Knell, 2004). John Hunter in 1767 inoculated matter 
from a patient whom believed to have gonorrhea onto into the prepuce and glans of a 
recipient, who traditionally is believed to be himself. Ten days after the inoculation, a chancre 
appeared, followed by signs of secondary syphilis. (Oriel, 1994). 
It is now believed that the donor had both syphilis and gonorrhea, but Hunter was 
convinced that he had induced syphilis by inoculation of gonorrheal pus. In 1838 Philippe 
Ricord demonstrated conclusively that syphilis and gonorrhea were separate diseases on 
over 2500 human inoculations and he was the first to propose a scheme for the 
categorization of syphilis into primary, secondary, and tertiary stages, which is still used 
today. In 1905 Schaudinn y Hoffman demonstrated spirochetes in Giemsa-stained smears 
(Schaudinn, 1905), August von Wasermann devised a serum reaction test for syphilis 
(Wasermann, 1906). The treatments for syphilis included mercury, organic arsenical 
compounds (Sartin, 1995).In 1943 Mahoney (Mahoney, 1943) successfully treated the first 
four cases with penicillin (table 1). 
1.2 Etiology 
Treponema Pallidum is a member of the order Spirochaetales, family Spirochaetaceae, and  genus 
Treponema. The pathogenic species are T.pallidum subsp. pallidum which causes venereal 
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1495 A widespread syphilis epidemic had Spreads throught Europe (Knell, 
2004). 
1767 John Hunter considerated that the disease to Neisseria gonorrhoeae and T. 
pallidum were the same (Oriel, 1994). 
1838 Philippe Ricord: first to propose a scheme of syphilis into primary, 
secondary, and tertiary stages. 
1859 Bazin: the term lues maligna was first used.  
1896 Third International Congress of Dermatology: lues maligna was classified 
as the ulcerative form of secondary syphilis.  
1897 Neisser and Haslund: clasic descriptions of lues maligna. 
1905 Schaudinn y Hoffman: demostrated spirochetes in Giemsa-stained 
smears. (Schaudinn, 1905) 
1906 Wasermann: first serologic test for syphilis. (Wasermann, 1906) 
1943 Mahoney: first who successfully treated four cases of syphilis with 
penicillin. (Mahoney, 1943) 
1988 Shulkin: first report HIV infected patient with lues maligna.  
Table 1. Historical aspects of syphilis.  
syphilis. T.pallidum subsp. endemicum, which causes endemic syphilis (bejel), T.subsp.pertenue 
which causes yaws, and T.carateum, which is the etiologic agent of pinta (Tramont,2010). The 
T.pallidum is a spirochete varying from 0.10 to 0.18 um in diameter and from 6-20 um in legth, 
making it invisible by light microscopy, for the visualization the Dark-field microscopy is 
generally used (Creigton, 1990). 
T. pallidum, cannot be cultivated in vitro, although limited multiplication can be obtained in 
tissue cultures (rabbits are the laboratory animals most commonly used for maintaining 
virulent organism), for this reason is difficult to study and determine its metabolic, physical, 
and pathogenic features. There were few physiologic studies have previously shown that the 
organism has limited biosynthetic capabilities, requiring multiple nutrients from the host 
(Fraser, 1998). However, genomic sequencing has provided some insights by suggesting 
functional activities. This consists of a single circular chromosome of approximately 1,138,006 
bases pairs, which places it close to the lowest end for the range of the bacteria. Unlike most 
pathogenic, its genome lacks apparent transponsable elements, suggesting that the genome is 
extremely conserved and stable. This is the likely explanation of why T.pallidum has remained 
exquisitely sensitive to penicillin for more than 70 year (Tramont, 2010). 
1.3 Epidemiology 
1.3.1 Transmission of disease 
The primary mode of transmission is by sexual contact and the next common is transfer 
across the placenta (Singh, 1999). Kissing, blood transfusion, and accidental inoculation have 
also been reported as routes of transmission but are of minor importance today. The 
majority of infants with congenital syphilis are in uterus, but the newborn can also be 
infected by contact with an active genital lesion at the time of delivery (Fiumara, 1975). 
Today, the acquisition of syphilis through transfused blood or blood products is now rare, at 
least in the developed world, because of the low incidence of disease, the requirement that 
all blood donors have a nonreactive non-treponemal blood test, and because T.pallidum 
cannot survive longer than 24 to 48 hours under the current conditions of blood bank 
storage (Tramond,2010).  
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Accidental direct inoculation can occur by needlestick or during handling of infected clinical 
material. Syphilis of the fingers is most common in medical personnel (Palfi, 2008). 
1.3.2 Occurrence of the disease 
In USA, prior to the penicillin age, the incidence in 1947 of primary and secondary syphilis 
was reported at 66.4 cases per 100,000 persons. Rates declined in 1956 to 3.9 cases per 
100,000 persons due to availability of penicillin, changes in sexual behaviour, and public 
health measures (Nakashima, 1996). The most recent epidemic was noted in 1990, with 
reported rates for primary and secondary syphilis at 20 per 100 000 persons, although no 
simple factor can explain this trend, and important contributing factor is crack cocaine use 
and the exchange of illegal drugs for sex (Rolf, 1990) (Fig.1). In USA, the rates fell to 2.1 cases 
per 100 000 in 2000, rising to 3 cases per 100 000 in 2005 (86% men). Actually the syphilis is a 
health problem with a prevalence of 12 million cases per year in worldwide (Hook, 2004). 
 
 
Fig. 1. Primary and Secondary Syphilis - Reported Rates: United States, 1970-2000 and the 
Healthy People Year 2010 Objective 
 
Australia & New Zealand 10 000 
North America 100 000 
Eastern Europe & Central Asia 100 000 
Western Europe 140 000 
East Asia & Pacific 240 000 
North Africa & the Middle East 370 000 
Latin America & the Caribbean 3 million 
sub-saharan Africa 4 million 
South & Southeast Asia 4 million 
Table 2. WHO estimates of number of new cases of Syphilis per year 
1.3.3 Syphilis, HIV, and men who have sex with men (MSM) 
Co-infection with syphilis and HIV is common due shared risk factors related to sexual 
behavior. In the USA, MSM have consistently represented the greatest single at risk group 
for HIV acquisition (Zetola, 2007). In Germany the rate is 75% (Ditzen, 2005). In Africa the 
prevalence of infection for HIV is 21% between MSM in comparation the 1-2% of general 
population (Wade, 2005). Some researchers have postulated that oral sex may now be more 
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common among MSM since it is associated with a reduced frequency of HIV transmission; 
however, syphilitic transmission from oral lesions is highly probably. 
1.4 Natural course of untreated syphilis 
Descriptions of the natural history of untreated syphilis originate primarily from two large 
prospective studies and one study retrospective study. Boeck performed a prospective 
natural history of 1978 patients with early syphilis in 1891. His observations 20 years were 
then continued by Brusgaars, and this information was later termed the Oslo Study. 
Between 1949 and 1951, Gjestland undertook a follow up of 1404 of the original 1978 
patients. The data were reviewed in 1955 and then recanalyzed in 1964 by Clark and 
Danbolt (Clark, 1964), the diagnoses were made clinically since neither serologic testing nor 
microscopy was available when the study began. The results indicate that approximately 
one-third of the patients developed tertiary manifestations of neurologic, cardiovascular, 
and gummatous (late benign) syphilis and that the probability of dying due to untreated 
syphilis was 17% and 8% in females (Table 3). 
 
 % 
Secondary syphilis 100 
Cured alter secondary syphilis 60% 
Tertiary syphilis  28% 
Tertiary syphilis; Late benign syphilis 15% males 17% females 
Tertiary syphilis; Cardiovascular syphilis 13,6% males, 7,6% females 
Tertiary syphilis; Neurosyphilis 9,4% males, 5,0% females.  
Mortality 17% males, 8% females.  
Table 3. Clinical Manifestations of Untreated Syphilis  
Rosahn retrospectively reviewed all autopsies at the Yale University School of Medicine 
from 1917 to 1941. Of 4000 autopsies of persons, 9.7% had evidence of syphilis, of them 77 
patients with untreated syphilis and late anatomic lesions at autopsy (83% had 
cardiovascular complications, 9% had late benign lesions, and 8% had neurosyphilis 
(Rosahn, 1947). There was an increased overall mortality in syphilitic compared with 
nonsyphilitic populations. 
1.5 Clinical manifestation 
T.pallidum penetrates the intact mucous membrane or gains access through abraded skin, it 
enters the lymphatics and bloodstream and disseminates throughout the body. Clinical 
lesions appear when a concentration of approximately 107 organisms/mg of tissue is 
reached (Magnuson, 1956). The incubation period is directly proportional to the size of the 
inoculums (3-90 days approximately). In untreated cases, syphilis has traditionally been 
divided into the following stages: incubating, primary, secondary, early latent, late latent 
and late tertiary syphilis. 
1.5.1 Primary syphilis 
The classic primary chancre begins at the site of inoculations as a single, occasionally 
multiple, painless papule. The base is usually smooth; the borders are raised are raised and 
firm and have a characteristic cartilaginous consistency (Stokes, 1944). The size of the 
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chancre varies from 0.3 to 3.0 cm, multiples chancres can occur especially in persons who are 
inmunosuppresed as those coinfected with HIV (Chapel,1978&Rompalo,2001).  
The localization, in men is the penis, more specifically the coronal sulcus and glans. 
Anorectal chancres are common in homosexual men (Horihan,2004). In women, the 
commonest locations of the lesions, in order of decreasing frequency, are the labia majora, 
labia minora, fourchette, and perineum. Regional lymphadenopathy consisting of 
moderately enlarged, firm, nonsuppurative, painless lymph nodes or satellite buboes 
usually accompanies the primary lesion (DiCarlo,1997). 
1.5.2 Secondary syphilis 
A rash of varying severity is the most common initial presenting symptom. This rash 
appears on the palms, soles, flanks, and arms and can range from macular to follicular and 
occasionally to pustular. Additionally up to 7% of patients may experience alopecia 
characterized by patchy hair loss of the scalp, beard, and lateral eyebrows, with is referred 
to as a moth-eaten appearance. Patients may also experience sore throats due to 
inflammatory involvement of the pharynx or the tonsils. Condiloma lata are found 5-22% of 
patients. Althoug the incidence of these effects is rare, syphilis can cause renal, 
ophthalmologic, hepatic, bone, and joint disease. 
1.5.3 Latent (early and late) syphilis 
Latent syphilis is a stage in which patients are seroreactive but asymptomatic. It occurs 
between the disappearance of secondary syphilis symptoms and the appearance of 
tertiary syphilis manifestations or therapeutic cure. About  90% of first relapses occur 
within 1 year , its defined early latent syphilis, and late latent syphilis is defined as 
occurring after 1 year (Gjestland, 1955). 
1.5.4 Tertiary syphilis 
Tertiary syphilis describes a broad range of manifestations but most commonly includes 
cardiovascular, gummatous, and/or neurological effects. Together, approximately 15% to 
40% of individuals who are not treated will develop tertiary manifestations, with men at 
increased risk compared with women. Cardiovascular complications are the most common 
of the effects and typically present within 10 to 30 years of infection. They often involve the 
aortic arch and can lead to angina from coronary ostitis, aortic regurgitation, or aortic 
aneurysm. Gummas can present in any organ and can lead to complications, including 
ulcers of the skin, collapse of the palate or nasal septum, or organomegaly. It can develop 
any time after a year of infection, but incidence peaks at approximately 15 years. 
1.6 Syphilis and HIV 
The coinfection have shown no distinctive or unique clinical presentation or pathologic 
manifestations from those without concurrent  HIV infection, they are at an increased risk to 
manifest a more protracted and malignant course, more constitutional symptoms, greater 
organ involvement, atypical and florid skin rashes, multiple genital ulcers in the 70% of 
patients (Rompalo,2010), 25% presented concomitant chancre during the secondary stage 
(Hutchinson, 1994), and a significant predisposition to develop symptomatic neurosyphilis 
(Tramont, 2010). 
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Stage of syphilis Clinical manifestations Percentage 
of cases
Incubation 
period 
Primary Chancre, regional lymphadenopathy 3 wk (3-90) 
Secondary Rash, condiloma latum, lymphadenopathy
Constitutional symptoms(fever, malaise, 
weight loss) 
 
Mouth and throat (mucous patches, erosions, 
ulcer) 
 
Genital lesions (chancre, condyloma latum, 
mucous patch) 
 
Central nervou system  
Asymptomatic 
Symptomatic  
90% 2-12 wk 
(2wk-6 
mos) 
70%
35%
20%
8-40%
Latent Asymptomatic Early,<1 yr; 
late,>1yr 
Tertiary. 
Cardiovascular 
Syphilis 
Aortic aneurisma, aortic regurgitation, 
coronary artery ostial stenosis 
10-30 yr 
Tertiary. Late 
neurosyphilis. 
Asymptomatic  
Asymptomatic 31% <2 yr 
Tertiary. Late 
neurosyphilis. Acute 
syphilitic meningitis 
Headache, meningeal irritation, confusion 1-2% <2 yr 
Tertiary. Late 
neurosyphilis. 
Meningovascular 
Hemiplejia, seizures, aphasia. 10% 5-7 yr 
Tertiary. Late 
neurosyphilis. 
General paresis 
Changes in personality, affect, sensorium, 
intellect, insight, and judgment. Hiperactive 
reflexes, speech disturbances, Argyll 
Robertson pupils.  
10-20 yr 
Tertiary. Late 
neurosyphilis. Tabes 
dorsalis 
Shooting or lightning pains into lower back 
or lower legs. Ataxia. Argyll Robertson 
pupils. Impotence. Blader disturbances. Fecal 
incontinence. Peripheral neuropathy. Romber
sign. Cranial nerve involvement 
15-20 yr 
Tertiary. 
Gummatous 
Syphilis.  
Monocytic infiltrates with tissue destruction 
of any organ 
15% 1-46 yr 
(most cases 
15 yr) 
Table 4. Clinical phases of syphilis 
1.6.1 Syphilis and HIV transmission  
The two diseases can affect each other in a number ways. Studies epidemiologist showed 
that the syphilis increasing the likelihood of acquisition of HIV (Buchacz, 2004, Reynolds, 
2006, Fleming 1999). 
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The acquisition and transmission of each other but syphilis also upregulates CCR5 
coreceptor expression (Sellati, 2000) and causes local inmune activation, thereby further 
increasing likelihood of adquisition of HIV, the  stimulation of syphilis infected patient 
immune system might induce replication of the virus (Quinn TC, 2000), decrease CD4 T cell 
counts and induce lymphocyte and CD4 apoptosis (Buchacz, 2004). 
The pathogenic interaction between HIV and T. pallidum leading both to an immunodeficiency 
state may reduce the immunologic response to treponemal infection through a decrease in 
CMI, macrophage functional defects, and possibly immunomodulation of the humoral 
immunity response. Functional immunologic abnormalities may impair the host defense 
against syphilis, leading to more aggressive forms.  
The serologic tests for syphilis may be modified, often resulting in extremely high titers 
(11% HIV-infected persons have a biologic false-positive serologic test result) and a failure 
to decrease in response to adequate treatment unless successfully treated with HAART. 
 
 References 
Genital ulcers can increase HIV 
transmision 
Telzac, 1993. 
T.pallidum induce the expression of CCR5 
on macrophages in syphilitic lesions 
Setalli, 2000 
T.pallidum decreased CD4 T-cell counts 
and increased HIV viral load 
Buchacz, 2004 
Syphilis increased HIV transmission 2-to9-
fold 
Chesson, 2003 
First six months after exposure of syphilis, 
represent the of greatest risk for HIV 
infection 
Reynolds, 2006 
Table 5. Syphilis and HIV transmission. 
1.6.1 Clinical features of syphilis in HIV-infected patients  
The majority of patients coinfected with HIV and syphilis have a primary syphilis similar to 
the population without HIV. However sometimes can show multiples chancres, larger and 
deeper and that heals more slowly (Hutchinson, 1994). The primary and secondary period 
overlap in 75% of cases (Rompalo, 2001). The signs of secondary syphilis can develop and 
succeed while chancres are still present. The rash may be more widespread and 
condylomata lata lesions more common than in patients without HIV.  
Unusual cutaneous manifestations, particularly the malignant lues are not uncommon in 
HIV patients. Acute syphilitic meningitis, ocular manifestations and losing hearing are more 
common in HIV patients (Tramont, 2005). The progression of tertiary syphilis is faster in 
HIV patients (Hutchinson, 1994) 
1.6.2 Diagnosis of syphilis in HIV-infected patients 
1.6.2.1 Identification of T.pallidum (Lesion-Based Testing) 
Direct fluorescent antibody test (DFA): A direct fluorescent antibody test can be performed 
on lesion exudate or tissue specimen. There are no differences in test performance 
characteristics among HIV-infected and non-infected patients.  
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Primary stage  Multiple chancres 
 Chancres larger, deeper, and resolve more slowly 
 Atypical chancres appearing as abrasions or fissures 
Secondary stage  Coincident chancres with signs of secondary syphilis 
 Duration of rash may be slightly longer, and rash may be 
widespread 
 Atypical skin rashes, including papular, nodular, 
ulceronudular (lues maligna) 
 Reports of ocular syphilis, mainly uveitis.  
 Retinitis, papillitis, and cranial nerve abnormalities II, III, 
or V in association with syphilitic meningitis.  
Tertiary syphilis; Late 
benign syphilis 
 Several reports of gummas 
 One case of rapid progresion to gumma within several 
months of a chancre 
 Located in multiple organ systems including the brain 
Tertiary syphilis; 
Cardiovascular syphilis
 Rare cases of rapidly developing aortitis reported 
Tertiary syphilis; 
Neurosyphilis 
 Progression to neurologic syphilis despite treatment of 
early syphilis 
 Reports of rapid progression to neurologic syphilis 
without long latency 
 Cases in patients with both normal and low CD4 counts 
 Clinical features include asymptomatic disease, 
meningitis, cranial nerve deficits, optic neuritis, myelitis, 
stroke, cerebral gummas
Table 6. Syphilis and HIV by stages. (Adapted from Syphilis. New York Department of 
Health AIDS Institute).  
Darkfield microscopy: Examination of exudate from an ulcer base or a mucocutaneous 
lesion under darkfield microscopy can identify the spirochete (T. pallidum). This test is 
invalid for oral samples. There are no differences in test performance characteristics among 
HIV-infected and non-infected patients.  
Silver stain: Spirochetes may be seen in biopsy specimens of suspicious lesions such as 
palmar macular rash or gummatous lesions. There are no differences in test performance 
characteristics among HIV-infected and non-infected patients.  
1.6.2.2 Serology 
The serology in patients co-infected syphilis and HIV are similar; however there are least 
differents in the serology but very important in the diagnostic (Table 7). 
2. Case report and discussion 
2.1 Case report 
A 42-year-old homeosexual man with chronic infection for HIV from 2003, in stadium A2 
without antiretroviral therapy consulted at the outpatient infection department at Juan 
Ramon Jimenez Hospital for fever of 38,5 º C of three weeks of evolution, which the patient  
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 Reference
False positive non-treponemal antibody test 
(RPR/VDRL). In one study, 4% of HIV-
infected patients tested had false-positive 
RPR results
Rompalo, 1992
Seroreactivity may be delayed or absent in 
HIV-infected patients. Rare cases have been 
reported of biopsy-proven secondary 
syphilis in HIV-infected patients with 
negative serology. 
Tikjob, 1991
Higher mean serologic serum non-
treponemal antibody levels than non-HIV-
infected 
Rolfs, 1997
Serum non-treponemal antibody levels may 
decline more slowly after treatment in HIV-
infected patients than non-infected patients
Rolfs, 1997, Yinnon 1996.  
Pro-zone reaction more commonly in HIV-
infected persons
Schöfer, 1996
Table 7. Considerations for serology in HIV-infected patients.  
relates to a "boil" perianal weeks before the beginning of the fever. On examination lymph 
nodes were palpable in the cervical, axillary and inguinal regions and skins lesions consisted 
of multiple erythematous present in his face, neck, trunk and extremities.  
One week after came back by persistence of the fever and pain of the throat. The laboratory 
studies revelead the following: Hemograme, glucose, urea, creatinine and ions were normal, 
GPT 71 U/l, GOT 50U/l, GGT 212 U/l, phosphatase alkaline 149 U/l. His CD4 cell count 
was 315/mm3 and his HIV viral load of 102.718 copies/ml. The Acid-fast bacilli stains, 
bacterial, fungal cultures and Lowenstein's culture in urine were all negative. The 
abdominal ultrasound scan was normal. Before the persistence of the clinic in absence of 
diagnosis the hospitable for continue the study.  
On examination, the patient was fever of 39 º C with stable vital signs. In mucous oral was 
presented whitish plates, didn't show ulcerative lesions or thrush (fig.1), skins lesions in 
different stages in trunk (fig. 2, panel A,B), face and neck, consisting of stains, papules, 
pustules with center necrotic and ulcerative scabs. He had and inguinal lymph node of 1-2 
cm, and cardiac, lung and abdominal examinations are benign. Neurologically, the patient 
was grossly intact without focal deficits.  
The C reactive-protein was 3,9 mg/dl and the erhytrocyte sedimentation rate was 99 
mm/hour. There were realized bacterial, fungal, mycobacterial culture and the blood 
detection of the antigen criptococo were normal. The Chest x-ray film was normal and the 
tomography thorax-abdominal didn't observe lesions in lung and in abdomen showed 
moderate enlargement hepatoesplenomegaly and lymphadenopathy in retroperitoneo, 
chains external ilíacas and inguinal approximately of 1,5 cm. 
The histological examination of the ganglionar biopsy showed reaction granulomatous giants 
cells without necrotic debris (fig. 3, panel A), didn't observe acid-fast bacilli fast and the fungal 
culture was negative. The skin biopsy punch revelead infiltrated lymphocytes, histiocytes with 
extensive areas of necrosis and debris, (fig. 3, panel B), the culture of this one (conventional, 
fungi and mycobacterial) was negative. Warthin-Starry's stain was negative in both samples.   
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Fig. 2. Mucous patches confused with oral candidiasis.  
 
 
Fig. 3. Noduloulcerative lesions of the trunk. Disseminated ulceronodular rash is affecting 
the trunk and abdomen (A) and back (B). The lesions are papules, pustules, pustules with 
necrosis central and ulcerated. 
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Treatment began with nistatine for the muguet. The presence of long fever, skin lesions, 
hepatoesplenomegaly and ganglionar affectation with noncaseating granuloma, suspected 
infection for Bartonella  beginning treatment with azitromicina (500 mg c/ 24 hours) with 
fever and decrease of the size of the inguinal lymphadenopathy. The serology's bartonella 
was negative <1/256 (IFI). The information together with the persistence of the fever and 
the skins lesions in a patient HIV forced us to reject the diagnosis of malignant Syphilis. The 
cerebrospinal fluid was without cell (VDRL negative). 
Empirical treatment began with injection of intramuscular benzathine penicillin (2,4 million 
UI) in only dose, the fever defervesced over the next 24 hours, receiving in ambulatory 
regime two additional doses weekly. He didn't present Jarish-Herxheimer's reaction. There 
began antiretroviral treatment of high efficiency based on tenofovir 300mg with 200 mg of 
emtricitabina and efavirenz 600mg every 24 hours. He was discharged from the hospital 
with this therapy.  
It was checked 10 days later in consultation being afebril and asymptomatic. The oral lesion 
had disappeared and the skins lesions ones were showing clear improvement. The syphilis 
serology showed a positive RPR titer 1/32, the immunoglobulin G was positive and the 
immunoglobulin M negative. The liver function test was normal three months after of the 
beginning the therapy. To six months RPR titer had descended to 1/4. 
The rash approximately coincided months before with inconsistent condom use and several 
new sexual relationships. 
 
 
Fig. 4. A) Biopsy lymph node: Nodular growth without central necrosis with lymphoid and 
plasma cell,  (H/E, original x 126). B) Biopsy skin: small base with  moderately dense 
perivascular lymphocitic infíltrate and deep dermis (H&E, original x 252).  
2.2 Discussion 
2.2.1 Definition 
Lues maligna was first described by Bazin (1859) and Dubuc (1864), who applied this term 
based on the bizarre clinical features and progressive course of this variant of syphilis. 
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During some decades, there was controversy about whether lues malignt was a severe 
variant of secondary syphilis or an early manifestation of tertiary syphilis; a question 
clarified by Haslund and Neisser in 1896-1897. In contrast to tertiary syphilis, the lesions of 
lues maligna are multiple, have a round or oval configuration, with no tendency to central 
healing, and exhibit a lamellated, brown-black rupioid crust. Moreover, the early onset of 
necrotic ulcers in the disease is in contrast to the later occurring gummas of tertiary syphilis. 
Neisser identified five clinical features of malignant syphilis: 
 
 Short incubation period 
 Constitutional symptoms are pronounced 
 The skin and frequently the mucous membranes of the mouth and nose present 
multiple irregularity distributed lesions consisting of large pustules, ulcers, and 
rupioid ecthymatous lesions 
 The patient may have characteristics of the milder forms of the disease such as 
mucous membrane buccal patches, etc. 
The skin lesions: 
 Pleomorphic 
 Papulopustules, beginning ulceration, deep ulceration, ulcers covered with crusts, 
healing lesions 
 Typically round or oval with a granulating base, and a lamellated, brown-black 
rupioid crust 
 The surrounding skin is little affected, showing only minimal erythema.  
Table 8. Criteria required for malign lues diagnosis (Neisser, 1896).  
 
Compatible gross and microscopic morphology 
A high titer serologic test for syphilis  
Herxheimer reaction 
Dramatic response to antibiotic therapy 
Table 9. Criteria required for malign lues diagnosis (Fisher, 1969).  
2.2.2 Risks factors for malignant lues  
The risks factors for malignant lues are: constitutional symptoms. MSM, sex, syphilis previous. 
Shulkin proposed the HIV and the presence of opportunistic infections (Shulkin, 1988). 
2.2.3 Incidence 
The incidence of malignant lues in the cases of series were 0.36% (Haslund, 1987) in the age 
pre-HIV and 7.3% after of the co-infection (Schofer,1996). 
2.2.4 Cases of ulceronodular syphilis in HIV patients 
Shulkin published in 1988 the first case of malignant lues in British language. We checked 
the characteristics epidemiologist, diagnostic, evolutions and treatments in patients with co-
infection ulceronodular syphilis-HIV from 1988 until 2010 (British and Spanish languages) 
including our case.  
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The total cases were 28 patients with mean age 33 years (R:18-61). There were twenty men 
and eight women. The risk factor most important was MSM in 45% of cases. The followed 
features are described in the next table. 
2.2.5 Serology 
The serology in patients with malignant syphilis is similar that the patients co-infected with 
syphilis-HIV presented high titles of non-treponemal antibody. 
2.2.6 Treatment 
The penicillin is the treatment of election. In the secondary syphilis (ulceronodular syphilis) 
the recommendation is only one dosis of  Benzathine PCN 2.4 million UI, however there are 
other authors than recommended to additional two dosis of penicillin  every one week to 
the initial treatment.  
3. Conclusion  
In the last years there was an increseased of cases of syphilis malign in relation with co-
infection HIV. Early and targeted recognition and treatment of both diseases is essential to 
deterring continued trends in incidence and prevalence of this disease. 
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